Abstract
Pulmonary hypertension (PHT) is a condition defined by a mean pulmonary arterial pressure (PAP) of 25 mmHg or greater at rest and 30 mmHg or greater during exercise. PHT can be idiopathic or associated with a wide spectrum of etiological factors and conditions in the pediatric population, often resulting in diagnostic and therapeutic challenges. Due to recent advances in treatment which have markedly decreased the mortality and morbidity in pediatric patients with PHT, early and accurate diagnosis is particularly essential in optimally managing children with PHT. In this chapter, we address the clinical presentation and the methods of evaluation of PHT in the pediatric population. Unique underlying pathophysiological processes and characteristic diagnostic study findings in idiopathic pulmonary arterial hypertension (IPAH) and common conditions typically associated with PHT in infants and children are also highlighted.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Abman SH, Hansmann G, Archer SL, et al. Pediatric pulmonary hypertension: guidelines from the American Heart Association and American Thoracic Society. Circulation. 2015;132(21):2037–99.
Nicholarsen J, Ivy D. Progress in the diagnosis and management of pulmonary hypertension in children. Curr Opin Pediatr. 2014;26(5):527–35.
Neptune E, Varghese N, Sockrider M. Pulmonary hypertension in children. Am J Respir Crit Care Med. 2017;196(8):15–6.
Haworth SG. The management of pulmonary hypertension in children. Arch Dis Child. 2008;93:620–5.
Rosenzweig EB, Barst RJ. Pulmonary arterial hypertension in children: a medical update. Curr Opin Pediatr. 2008;20:288–93.
Rosenzweig EB, Widlitz AC, Barst RJ. Pulmonary arterial hypertension in children. Pediatr Pulmonol. 2004;38:2–22.
Simonneau G, Galie N, Rubin LJ, et al. Clinical classification of pulmonary hypertension. J Am Coll Cardiol. 2004;43:5S–12.
Vorhies EE, Gajarski RJ, Yu S, Donohue JE, Figer CG. Echocardiographic evaluation of ventricular function in children with pulmonary hypertension. Pediatr Cardiol. 2014;35(5):759–66.
LaRaia AV, Waxman AB. Pulmonary arterial hypertension: evaluation and management. South Med J. 2007;100:393–9.
Zuk M, Migdal A, Jagiellowicz-Kowalska D, et al. Six-minute walk test in evaluation of children with pulmonary arterial hypertension. Pediatr Cardiol. 2017;38(4):754–61.
Gabbay E, Reed A, Williams TJ. Assessment and treatment of pulmonary arterial hypertension: an Australian perspective in 2006. Intern Med J. 2007;37:38–48.
Matsuura H. Cardiac catheterization in children with pulmonary arterial hypertension. Pediatr Int. 2017;59(1):3–9.
Johns CS, Kiely DG, Swift AJ. Novel imaging techniques in pulmonary hypertension. Curr Opin Cardiol. 2018;33(6):587–93.
Rosenzweig EB, Barst RJ. Idiopathic pulmonary arterial hypertension in children. Curr Opin Pediatr. 2005;17:372–80.
Widlitz A, Barst RJ. Pulmonary arterial hypertension in children. Eur Respir J. 2003;21:155–76.
Lammers AE, Hislop AA, Flynn Y, et al. Epoprostenol treatment in children with severe pulmonary hypertension. Heart. 2007;93:739–43.
Ng CS, Wells AU, Padley SP. A CT sign of chronic pulmonary arterial hypertension: the ratio of main pulmonary artery to aortic diameter. J Thorac Imaging. 1999;14:270–8.
Chaudry G, MacDonald C, Adatia I, et al. CT of the chest in the evaluation of idiopathic pulmonary arterial hypertension in children. Pediatr Radiol. 2007;37:345–50.
King MA, Ysrael M, Bergin CJ. Chronic thromboembolic pulmonary hypertension: CT findings. AJR Am J Roentgenol. 1998;170:955–60.
Resten A, Maitre S, Humbert M, et al. Pulmonary hypertension: CT of the chest in pulmonary venoocclusive disease. AJR Am J Roentgenol. 2004;183:65–70.
McCann GP, Gan CT, Beek AM, et al. Extent of MRI delayed enhancement of myocardial mass is related to right ventricular dysfunction in pulmonary artery hypertension. AJR Am J Roentgenol. 2007;188:349–55.
Fukuchi K, Hayashida K, Nakanishi N, et al. Quantitative analysis of lung perfusion in patients with primary pulmonary hypertension. J Nucl Med. 2002;43:757–61.
Ogawa Y, Nishimura T, Hayashida K, et al. Perfusion lung scintigraphy in primary pulmonary hypertension. Br J Radiol. 1993;66:677–80.
Wood P. The Eisenmenger syndrome or pulmonary hypertension with reversed central shunt. I. Br Med J. 1958;2:701–9.
van Albada ME, Berger RM. Pulmonary arterial hypertension in congenital cardiac disease – the need for refinement of the Evian-Venice classification. Cardiol Young. 2008;18:10–7.
Daliento L, Somerville J, Presbitero P, et al. Eisenmenger syndrome. Factors relating to deterioration and death. Eur Heart J. 1998;19:1845–55.
Sheehan R, Perloff JK, Fishbein MC, et al. Pulmonary neovascularity: a distinctive radiographic finding in Eisenmenger syndrome. Circulation. 2005;112:2778–85.
Griffin N, Allen D, Wort J, et al. Eisenmenger syndrome and idiopathic pulmonary arterial hypertension: do parenchymal lung changes reflect aetiology? Clin Radiol. 2007;62:587–95.
Perloff JK, Hart EM, Greaves SM, et al. Proximal pulmonary arterial and intrapulmonary radiologic features of Eisenmenger syndrome and primary pulmonary hypertension. Am J Cardiol. 2003;92:182–7.
Sun SS, Tsai MK, Yang CH, et al. Atrial septal defect with Eisenmenger’s syndrome confirmed by Tc-99m MAA scintigraphy. Clin Nucl Med. 2002;27:219–20.
Woemer C, Cutz E, Yoo SJ, Grasemann H, Humpl T. Pulmonary veno-occlusive disease in childhood. Chest. 2014;146(1):167–74.
Ozsoyoglu AA, Swartz J, Farver CF, et al. High-resolution computed tomographic imaging and pathologic features of pulmonary veno-occlusive disease: a review of three patients. Curr Probl Diagn Radiol. 2006;35:219–23.
Holcomb BW Jr, Loyd JE, Ely EW, et al. Pulmonary veno-occlusive disease: a case series and new observations. Chest. 2000;118:1671–9.
Frazier AA, Franks TJ, Mohammed TL, et al. From the Archives of the AFIP: pulmonary veno-occlusive disease and pulmonary capillary hemangiomatosis. Radiographics. 2007;27:867–82.
Engelke C, Schaefer-Prokop C, Schirg E, et al. High-resolution CT and CT angiography of peripheral pulmonary vascular disorders. Radiographics. 2002;22:739–64.
O’Keefe MC, Post MD. Pulmonary capillary hemangiomatosis: a rare cause of pulmonary hypertension. Arch Pathol Lab Med. 2015;139(2):274–7.
Faria IM, Carmeiro LH, Tiradentes TA, Zanetti G, Marchiori E. Pulmonary capillary hemangiomatosis: an uncommon cause of pulmonary hypertension. J Bras Pneumol. 2013;29(3):390–2.
Lippert JL, White CS, Cameron EW, et al. Pulmonary capillary hemangiomatosis: radiographic appearance. J Thorac Imaging. 1998;13:49–51.
El-Gabaly M, Farver CF, Budev MA, et al. Pulmonary capillary hemangiomatosis imaging findings and literature update. J Comput Assist Tomogr. 2007;31:608–10.
Ito K, Ichiki T, Ohi K, et al. Pulmonary capillary hemangiomatosis with severe pulmonary hypertension. Circ J. 2003;67:793–5.
Rush C, Langleben D, Schlesinger RD, et al. Lung scintigraphy in pulmonary capillary hemangiomatosis. A rare disorder causing primary pulmonary hypertension. Clin Nucl Med. 1991;16:913–7.
Almagro P, Julia J, Sanjaume M, et al. Pulmonary capillary hemangiomatosis associated with primary pulmonary hypertension: report of 2 new cases and review of 35 cases from the literature. Medicine (Baltimore). 2002;81:417–24.
Dakshinamurti S. Pathophysiologic mechanisms of persistent pulmonary hypertension of the newborn. Pediatr Pulmonol. 2005;39:492–503.
Allen K, Haworth SG. Human postnatal pulmonary arterial remodeling. Ultrastructural studies of smooth muscle cell and connective tissue maturation. Lab Investig. 1988;59:702–9.
Bendapudi P, Rao GG, Greenough A. Diagnosis and management of persistent pulmonary hypertension of the newborn. Paediatr Respir Rev. 2015;16(3):157–61.
Steinhorn RH. Neonatal pulmonary hypertension. Pediatr Crit Care Med. 2010;11(2 Suppl):S79–84.
McLeod KA, Gerlis LM, Williams GJ. Morphology of the elastic pulmonary arteries in pulmonary hypertension: a quantitative study. Cardiol Young. 1999;9:364–70.
Atkinson JB, Ford EG, Kitagawa H, et al. Persistent pulmonary hypertension complicating cystic adenomatoid malformation in neonates. J Pediatr Surg. 1992;27:54–6.
Farrow KN, Fliman P, Steinhorn RH. The diseases treated with ECMO: focus on PPHN. Semin Perinatol. 2005;29:8–14.
Antao B, Samuel M, Kiely E, et al. Congenital alveolar capillary dysplasia and associated gastrointestinal anomalies. Fetal Pediatr Pathol. 2006;25:137–45.
Roy PG, Patel P, Vayalakkad A, et al. Alveolar capillary dysplasia presenting as pneumothorax: a case report and review of literature. Pediatr Surg Int. 2007;23:915–7.
Bardo DM, Frankel DG, Applegate KE, et al. Hypoplastic left heart syndrome. Radiographics. 2001;21:705–17.
Endo M, Yamaki S, Ohmi M, et al. Pulmonary vascular changes induced by congenital obstruction of pulmonary venous return. Ann Thorac Surg. 2000;69:193–7.
Gudjonsson U, Brown JW. Scimitar syndrome. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu. 2006;9:56–62.
Yamaki S, Tsunemoto M, Shimada M, et al. Quantitative analysis of pulmonary vascular disease in total anomalous pulmonary venous connection in sixty infants. J Thorac Cardiovasc Surg. 1992;104:728–35.
Yamaki S, Endo M, Takahashi T. Different grades of medial hypertrophy and intimal changes in small pulmonary arteries among various types of congenital heart disease with pulmonary hypertension. Tohoku J Exp Med. 1997;182:83–91.
Ghofrani HA, Voswinckel R, Reichenberger F, et al. Hypoxia- and non-hypoxia-related pulmonary hypertension – established and new therapies. Cardiovasc Res. 2006;72:30–40.
Howell K, Ooi H, Preston R, et al. Structural basis of hypoxic pulmonary hypertension: the modifying effect of chronic hypercapnia. Exp Physiol. 2004;89:66–72.
Tracy MC, Cornfield DN. The evolution of disease: chronic lung disease of infancy and pulmonary hypertension. Curr Opin Pediatr. 2017;29(3):320–5.
Nagiub M, Kanaan U, Simon D, Guglani L. Risk factors for development of pulmonary hypertension in infants with bronchopulmonary dysplasia: systematic review and meta-analysis. Paediatr Respir Rev. 2017;23:27–32.
Stenmark KR, Abman SH. Lung vascular development: implications for the pathogenesis of bronchopulmonary dysplasia. Annu Rev Physiol. 2005;67:623–61.
Griscom NT, Wheeler WB, Sweezey NB, et al. Bronchopulmonary dysplasia: radiographic appearance in middle childhood. Radiology. 1989;171:811–4.
Howling SJ, Northway WH Jr, Hansell DM, et al. Pulmonary sequelae of bronchopulmonary dysplasia survivors: high-resolution CT findings. AJR Am J Roentgenol. 2000;174:1323–6.
Husain AN, Siddiqui NH, Stocker JT. Pathology of arrested acinar development in postsurfactant bronchopulmonary dysplasia. Hum Pathol. 1998;29:710–7.
Rovedder PM, Ziegler B, Pinotti AF, et al. Prevalence of pulmonary hypertension evaluated by Doppler echocardiography in a population of adolescent and adult patients with cystic fibrosis. J Bras Pneumol. 2008;34:83–90.
Keller RL. Antenatal and postnatal lung and vascular anatomic and functional studies in congenital diaphragmatic hernia: implications for clinical management. Am J Med Genet C Semin Med Genet. 2007;145C:184–200.
Kitagawa M, Hislop A, Boyden EA, et al. Lung hypoplasia in congenital diaphragmatic hernia. A quantitative study of airway, artery, and alveolar development. Br J Surg. 1971;58:342–6.
Dillon PW, Cilley RE, Mauger D, et al. The relationship of pulmonary artery pressure and survival in congenital diaphragmatic hernia. J Pediatr Surg. 2004;39:307–12; discussion 307–12.
Andrew M, David M, Adams M, et al. Venous thromboembolic complications (VTE) in children: first analyses of the Canadian Registry of VTE. Blood. 1994;83:1251–7.
Anton N, Massicotte MP. Venous thromboembolism in pediatrics. Semin Vasc Med. 2001;1:111–22.
Babyn PS, Gahunia HK, Massicotte P. Pulmonary thromboembolism in children. Pediatr Radiol. 2005;35:258–74.
Chan AK, Deveber G, Monagle P, et al. Venous thrombosis in children. J Thromb Haemost. 2003;1:1443–55.
Revel-Vilk S, Massicotte P. Thromboembolic diseases of childhood. Blood Rev. 2003;17:1–6.
Schmidt B, Andrew M. Neonatal thrombosis: report of a prospective Canadian and international registry. Pediatrics. 1995;96:939–43.
Lee EY, Tse SK, Zurakowski D, et al. Children suspected of having pulmonary embolism: multidetector CT pulmonary angiography – thromboembolic risk factors and implications for appropriate use. Radiology. 2012;262(1):242–51.
Dartevelle P, Fadel E, Mussot S, et al. Chronic thromboembolic pulmonary hypertension. Eur Respir J. 2004;23:637–48.
Moser KM, Bloor CM. Pulmonary vascular lesions occurring in patients with chronic major vessel thromboembolic pulmonary hypertension. Chest. 1993;103:685–92.
Kreitner KF, Kunz RP, Ley S, et al. Chronic thromboembolic pulmonary hypertension – assessment by magnetic resonance imaging. Eur Radiol. 2007;17:11–21.
Elwing JM, Vaidya A, Auger WR. Chronic thromboembolic pulmonary hypertension: an update. Clin Chest Med. 2018;39(3):605–20.
Auger WR, Kim NH, Kerr KM, et al. Chronic thromboembolic pulmonary hypertension. Clin Chest Med. 2007;28:255–69. x.
Kritsaneepaiboon S, Lee EY, Zurakowoski D, et al. MDCT pulmonary angiography evaluation of pulmonary embolism in children. AJR Am J Roentgenol. 2009;192(5):1246–52.
Schoepf UJ. Diagnosing pulmonary embolism: time to rewrite the textbooks. Int J Cardiovasc Imaging. 2005;21:155–63.
Lee EY, Kritsaneepaiboon S, Arellano CM, et al. Unsuspected pulmonary emboli in pediatric oncology patients: detection with MDCT. AJR Am J Roentgenol. 2010;194(5):1216–22.
Lee EY, Zurakowski D, Boiselle PM. Pulmonary embolism in pediatric patients: survey of CT pulmonary angiography practices and policies. Acad Radiol. 2010;17(12):1543–9.
Thacker PG, Lee EY. Pulmonary embolism in children. AJR Am J Roentgenol. 2015;204(6):1278–88.
Thacker PG, Lee EY. Advances in multidetector CT diagnosis of pediatric pulmonary thromboembolism. Korean J Radiol. 2016;17(2):198–208.
Liszewski MC, Hersman FW, Altes TA, et al. Magnetic resonance imaging of pediatric lung parenchyma, airways, vasculature, ventilation, and perfusion: sate of the art. Radiol Clin N Am. 2013;51(4):555–82.
Shilo NR, Morris CR. Pathways to pulmonary hypertension in sickle cell disease: the search for prevention and early intervention. Expert Rev Hematol. 2017;10(10):875–90.
Onyekwere OC, Campbell A, Teshome M, et al. Pulmonary hypertension in children and adolescents with sickle cell disease. Pediatr Cardiol. 2008;29:309–12.
Machado RF. Sickle cell anemia-associated pulmonary arterial hypertension. J Bras Pneumol. 2007;33:583–91.
Machado RF, Gladwin MT. Chronic sickle cell lung disease: new insights into the diagnosis, pathogenesis and treatment of pulmonary hypertension. Br J Haematol. 2005;129:449–64.
Barnett CF, Hsue PY, Machado RF. Pulmonary hypertension: an increasingly recognized complication of hereditary hemolytic anemias and HIV infection. JAMA. 2008;299:324–31.
Aessopos A, Farmakis D. Pulmonary hypertension in beta-thalassemia. Ann N Y Acad Sci. 2005;1054:342–9.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Lee, E.Y., Chaudry, G. (2020). Pulmonary Hypertension. In: Cleveland, R., Lee, E. (eds) Imaging in Pediatric Pulmonology. Springer, Cham. https://doi.org/10.1007/978-3-030-23979-4_12
Download citation
DOI: https://doi.org/10.1007/978-3-030-23979-4_12
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-23978-7
Online ISBN: 978-3-030-23979-4
eBook Packages: MedicineMedicine (R0)